TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 9758086

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS monotherapy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hydrochlorothiazide (HCTZ) monotherapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine GITS alone or in combination with HCTZ
Number of subjects: 0
Study: 8110558

Group type: EXPERIMENTAL
Intervention: Neostigmine 20 micrograms kg‐1 at profound block (5-10% recovery)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Neostigmine 40 micrograms kg‐1 at profound block (5-10% recovery)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Neostigmine 20, 40, or 80 micrograms kg‐1 at light block (40-50% recovery)
Number of subjects: 57

Group type: EXPERIMENTAL
Intervention: Neostigmine 20 micrograms kg‐1 at light block (40-50% recovery)
Number of subjects: 57
Study: 3377211

Group type: EXPERIMENTAL
Intervention: Continuous epidural infusion of fentanyl 10 micrograms/ml with bupivacaine 0.1%
Number of subjects: 107

Group type: COMPARATOR
Intervention: Continuous epidural infusion of morphine 0.1 mg/ml with bupivacaine 0.1%
Number of subjects: 107
Study: 29603591

Group type: EXPERIMENTAL
Intervention: Vorinostat 430 mg/m2/day (days 1-4; 8-11) in combination with isotretinoin 80 mg/m2/dose (days 1-14)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Vorinostat 430 mg/m2/day (days 1-4; 8-11)
Number of subjects: 29
Study: 26503614

Group type: EXPERIMENTAL
Intervention: Oral immunotherapy (OIT) for cows' milk allergy
Number of subjects: 28
Study: 25593233

Group type: EXPERIMENTAL
Intervention: apremilast 20 mg BID
Number of subjects: 504

Group type: EXPERIMENTAL
Intervention: apremilast 30 mg BID
Number of subjects: 504

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 504
Study: 23878381

Group type: EXPERIMENTAL
Intervention: Shoes on
Number of subjects: 33

Group type: COMPARATOR
Intervention: Shoes off
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Visual condition (eyes open)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: Visual condition (eyes closed)
Number of subjects: 33
Study: 20944074

Group type: EXPERIMENTAL
Intervention: EZG (RTG) 600 mg/d
Number of subjects: 538

Group type: EXPERIMENTAL
Intervention: EZG (RTG) 900 mg/d
Number of subjects: 538

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 538
Study: 18187486

Group type: EXPERIMENTAL
Intervention: Breast conservation therapy (BCT)
Number of subjects: 9388

Group type: COMPARATOR
Intervention: Mastectomy (MT)
Number of subjects: 9388
Study: 16298249

Group type: EXPERIMENTAL
Intervention: Estradiol (2mg per day)
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 12823389

Group type: EXPERIMENTAL
Intervention: Drotaverine hydrochloride (80 mg, intravenous, with possible repeat dose)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102
Study: 9685441

Group type: EXPERIMENTAL
Intervention: Knowledge and attitude program and adaptation of physical education (8-week intervention)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Risk-based intervention (8-week intervention)
Number of subjects: 422

Group type: COMPARATOR
Intervention: Control group (usual teaching and physical education)
Number of subjects: 422

Group type: EXPERIMENTAL
Intervention: Both intervention groups
Number of subjects: 422
Study: 7851466

Group type: EXPERIMENTAL
Intervention: Combination of tropisetron plus ketanserin
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Ondansetron
Number of subjects: 5

Group type: COMPARATOR
Intervention: Cholera toxin alone
Number of subjects: 5

Group type: EXPERIMENTAL
Intervention: Tropisetron alone
Number of subjects: 5
Study: 2647123

Group type: EXPERIMENTAL
Intervention: Nifedipine (20 mg to 60 mg daily)
Number of subjects: 0
Study: 1106185

Group type: EXPERIMENTAL
Intervention: Endoscopy
Number of subjects: 60

Group type: COMPARATOR
Intervention: UGI barium series
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Endoscopy and UGI series
Number of subjects: 60
Study: 31023005

Group type: EXPERIMENTAL
Intervention: MMI + Se
Number of subjects: 103

Group type: COMPARATOR
Intervention: MMI
Number of subjects: 103
Study: 28789468

Group type: EXPERIMENTAL
Intervention: mNMES
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: nNMES
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: iNMES
Number of subjects: 0
Study: 23351836

Group type: EXPERIMENTAL
Intervention: Internet-based aftercare with weekly writing tasks and therapeutic feedback, a patient forum, a self-test and relaxation exercises (n = 400)
Number of subjects: 800

Group type: COMPARATOR
Intervention: Regular e-mail reminders with links to publicly accessible information about stress management and coping (Control group, n = 400)
Number of subjects: 800
Study: 21288539

Group type: EXPERIMENTAL
Intervention: C‐AT (computer-assisted treatment program, My Sentence Builder)
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: nC‐AT (non computer-assisted treatment, conventional language stimulation procedures)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 34
Study: 19853105

Group type: EXPERIMENTAL
Intervention: FloSeal matrix sealant
Number of subjects: 415

Group type: COMPARATOR
Intervention: Alternative topical hemostatic agents
Number of subjects: 415
Study: 17368254

Group type: EXPERIMENTAL
Intervention: Oxytocin infusion (2 ampules of oxytocin at 10 u/mL/amp added to 1000 mL saline at 40 mU/min)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (without oxytocin infusion)
Number of subjects: 60
Study: 15222727

Group type: EXPERIMENTAL
Intervention: Test formulation of ciprofloxacin 750 mg (supplied by Dr. August Wolff GmbH and Co., Germany)
Number of subjects: 24
Study: 11494803

Group type: EXPERIMENTAL
Intervention: Mailed guidelines and seminars to school teachers
Number of subjects: 0
Study: 10026839

Group type: EXPERIMENTAL
Intervention: SR 49059 1 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SR 49059 10 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SR 49059 100 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SR 49059 300 mg
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: SR 49059 600 mg
Number of subjects: 50

Group type: COMPARATOR
Intervention: AVP (control)
Number of subjects: 50
Study: 7987490

Group type: EXPERIMENTAL
Intervention: Oral haloperidol
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intramuscular haloperidol decanoate
Number of subjects: 0
Study: 2106534

Group type: EXPERIMENTAL
Intervention: Haloperidol in combination with carbamazepine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Haloperidol in combination with lithium carbonate
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Haloperidol with added carbamazepine
Number of subjects: 0
Study: 785949

Group type: EXPERIMENTAL
Intervention: Carbamazepine
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 30925157

Group type: EXPERIMENTAL
Intervention: CRADLE intervention (novel vital sign device and training package)
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Eclampsia cases
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate availability
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Stillbirth or neonatal death
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Age distribution of eclampsia cases
Number of subjects: 536233

Group type: EXPERIMENTAL
Intervention: Place of first eclamptic fit
Number of subjects: 536233
Study: 29077152

Group type: EXPERIMENTAL
Intervention: High molecular weight Sodium Hyaluronate (3%) plus saline solution (NaCl 0.9%) twice a day for 30 days
Number of subjects: 48

Group type: COMPARATOR
Intervention: Saline solution twice a day for 30 days
Number of subjects: 48
Study: 25451987

Group type: EXPERIMENTAL
Intervention: Office visit with a primary care physician within 7 days after discharge
Number of subjects: 3661

Group type: EXPERIMENTAL
Intervention: Office visit with any physician within 7 days after discharge
Number of subjects: 3661

Group type: COMPARATOR
Intervention: No office visit within 7 days after discharge
Number of subjects: 3661
Study: 23981905

Group type: EXPERIMENTAL
Intervention: Text message follow-up
Number of subjects: 710

Group type: COMPARATOR
Intervention: Online follow-up
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Text message follow-up (Black men)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Online follow-up (Black men)
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Text message follow-up (Hispanic men)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Online follow-up (Hispanic men)
Number of subjects: 710

Group type: EXPERIMENTAL
Intervention: Text message follow-up (White men)
Number of subjects: 710

Group type: COMPARATOR
Intervention: Online follow-up (White men)
Number of subjects: 710
Study: 21613972

Group type: EXPERIMENTAL
Intervention: Cemented Exeter V40 stem with torsional loading (group I)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cemented Exeter V40 stem with anterior loading (group II)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cemented Exeter V40 stem with lateral loading (group III)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Uninstrumented femurs tested in a four-point bending assay (group IV and V)
Number of subjects: 20
Study: 19372111

Group type: EXPERIMENTAL
Intervention: Lip repair with an Abbé flap
Number of subjects: 2

Group type: COMPARATOR
Intervention: Healthy volunteers
Number of subjects: 2
Study: 16944822

Group type: EXPERIMENTAL
Intervention: Stimulo device intervention (active and passive range of motion of the ankle, performed three times a week for 30 min over six weeks)
Number of subjects: 18
Study: 16326693

Group type: COMPARATOR
Intervention: 2-week antimicrobial protocol
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 3-week antimicrobial protocol
Number of subjects: 80
Study: 13678770

Group type: EXPERIMENTAL
Intervention: Alendronate 2.5-10 mg per day for 2 years
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Alendronate for 4 years
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Alendronate for 6 years
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Alendronate 20 mg per day for 2 years
Number of subjects: 203

Group type: COMPARATOR
Intervention: Alendronate withdrawal
Number of subjects: 203

Group type: EXPERIMENTAL
Intervention: Bone markers
Number of subjects: 203
Study: 10515039

Group type: EXPERIMENTAL
Intervention: Alisate (300 mg, 1 tablet twice a day for 4-6 weeks)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Conventional antirheumatic therapy
Number of subjects: 30
Study: 7556959

Group type: EXPERIMENTAL
Intervention: recombinant human IGF‐I (rhIGF‐I) (10 micrograms.kg‐1.h‐1 s.c.)
Number of subjects: 8

Group type: COMPARATOR
Intervention: saline
Number of subjects: 8
Study: 1702977

Group type: EXPERIMENTAL
Intervention: Lactated Ringer's (RL group, n = 6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 10% hydroxyethyl starch (HES group, n = 6)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: 20% human albumin (HA group, n = 6)
Number of subjects: 18
Study: 438427

Group type: EXPERIMENTAL
Intervention: Experimental condition (N = 32) with individually designed prescriptive techniques implemented by trained college student aides.
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo control (N = 32).
Number of subjects: 64
Study: 30942034

Group type: EXPERIMENTAL
Intervention: Acupuncture and tuina combined with phacoemulsification
Number of subjects: 68

Group type: COMPARATOR
Intervention: Phacoemulsification
Number of subjects: 68
Study: 29112963

Group type: EXPERIMENTAL
Intervention: Combination intervention strategy (CIS)
Number of subjects: 2197

Group type: COMPARATOR
Intervention: Standard of care (SOC)
Number of subjects: 2197

Group type: EXPERIMENTAL
Intervention: CIS
Number of subjects: 2197

Group type: COMPARATOR
Intervention: SOC
Number of subjects: 2197
Study: 25835622

Group type: EXPERIMENTAL
Intervention: Intermediate Dose (ID) - 76.8Gy < BED 10 < 100.8 Gy (e.g., >64 Gy/32 fr and <74 Gy/37 fr)
Number of subjects: 1274

Group type: COMPARATOR
Intervention: Standard Dose (SD) - 72Gy ≤ BED 10 ≤ 76.8 Gy (e.g., 60‐64 Gy/30‐32 fractions)
Number of subjects: 1274

Group type: EXPERIMENTAL
Intervention: Intermediate Dose (ID)
Number of subjects: 1274
Study: 24270132

Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study: 21458622

Group type: EXPERIMENTAL
Intervention: Vitamin C and E supplementation
Number of subjects: 1187

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1187
Study: 19536605

Group type: EXPERIMENTAL
Intervention: Continued pharmacological treatment
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Early invasive treatment
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Severe myocardial ischemia
Number of subjects: 319

Group type: EXPERIMENTAL
Intervention: Insulin use
Number of subjects: 319
Study: 16776781

Group type: EXPERIMENTAL
Intervention: Eyeglasses and magnifiers (immediate intervention group)
Number of subjects: 131

Group type: COMPARATOR
Intervention: Control group (prescription and voucher after 3 months)
Number of subjects: 131
Study: 14757691

Group type: EXPERIMENTAL
Intervention: Stent deployment in diabetic patients
Number of subjects: 418

Group type: COMPARATOR
Intervention: Stent deployment in nondiabetic patients
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Smaller vessel reference diameter (RD)
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Greater stented length of vessel
Number of subjects: 418

Group type: EXPERIMENTAL
Intervention: Reduced body mass index (BMI)
Number of subjects: 418
Study: 11579891

Group type: COMPARATOR
Intervention: Sulfadoxine-pyrimethamine (SP) - dosage: pyrimethamine 1.25 mg/kg and sulfadoxine 25 mg/kg, single dose
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Proguanil (PG) plus Dapsone (DS) - dosage: PG 10 mg/kg and DS 2.5 mg/kg each day for 3 days
Number of subjects: 220

Group type: EXPERIMENTAL
Intervention: Proguanil (PG) plus Dapsone (DS)
Number of subjects: 220
Study: 9443139

Group type: EXPERIMENTAL
Intervention: Massage therapy in addition to coaching in breathing from partners during labor
Number of subjects: 28

Group type: COMPARATOR
Intervention: Coaching in breathing alone
Number of subjects: 28
Study: 8098885

Group type: EXPERIMENTAL
Intervention: Nootropic piracetam (daily dosage 1.2 g)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 3755554

Group type: EXPERIMENTAL
Intervention: Brufen 200 mg tablets
Number of subjects: 18

Group type: COMPARATOR
Intervention: Inza 200 mg and 400 mg tablets
Number of subjects: 18
Study: 31805385

Group type: EXPERIMENTAL
Intervention: Preoperative fascia iliaca block (35-40 mL ropivacaine 0.35%)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no fascia iliaca block)
Number of subjects: 60
Study: 31390801

Group type: EXPERIMENTAL
Intervention: Bioactive-enriched food combinations (specific combinations not detailed)
Number of subjects: 167
Study: 28483183

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation at the thoracolumbar sympathetic ganglions
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical nerve stimulation at acupuncture points
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (mid-calf area stimulation)
Number of subjects: 75
Study: 25927539

Group type: EXPERIMENTAL
Intervention: CATCH-IT (Competent Adulthood Transition with Cognitive Behavioral Humanistic and Interpersonal Training)
Number of subjects: 234

Group type: COMPARATOR
Intervention: General health education Internet intervention
Number of subjects: 234
Study: 23169797

Group type: EXPERIMENTAL
Intervention: Diffusion-tensor imaging (DT) at 3T
Number of subjects: 40
Study: 21854279

Group type: EXPERIMENTAL
Intervention: HIV-risk reduction intervention
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Zero-inflated negative binomial (ZINB) model
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Negative binomial (NB) model
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Zero-inflated Poisson (ZIP) model
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Poisson hurdle (PH) model
Number of subjects: 515

Group type: EXPERIMENTAL
Intervention: Negative binomial hurdle (NBH) model
Number of subjects: 515
Study: 19369319

Group type: EXPERIMENTAL
Intervention: haloperidol (1 to 4 mg/day)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: amisulpride (200 to 800 mg/day)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: olanzapine (5 to 20 mg/day)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: quetiapine (200 to 750 mg/day)
Number of subjects: 498

Group type: EXPERIMENTAL
Intervention: ziprasidone (40 to 160 mg/day)
Number of subjects: 498

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 498
Study: 16330155

Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Stress Management (CBSM) training
Number of subjects: 28

Group type: COMPARATOR
Intervention: Waiting control condition
Number of subjects: 28
Study: 15253956

Group type: EXPERIMENTAL
Intervention: Testosterone replacement therapy (Sustanon 100)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 11849859

Group type: EXPERIMENTAL
Intervention: Probucol (500 mg/day, n = 82)
Number of subjects: 246

Group type: EXPERIMENTAL
Intervention: Pravastatin (10 mg/day, n = 83)
Number of subjects: 246

Group type: COMPARATOR
Intervention: Control group (diet alone, n = 81)
Number of subjects: 246
Study: 9688105

Group type: EXPERIMENTAL
Intervention: Sibutramine (10 mg once daily)
Number of subjects: 226

Group type: COMPARATOR
Intervention: Dexfenfluramine (15 mg twice daily)
Number of subjects: 226

Group type: EXPERIMENTAL
Intervention: Both drugs
Number of subjects: 226
Study: 7526440

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: co-trimoxazole
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no treatment mentioned)
Number of subjects: 60
Study: 2690972

Group type: EXPERIMENTAL
Intervention: Aminoglutethimide (AG)
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Megestrol acetate (MA)
Number of subjects: 176
Study: 4574642

Group type: EXPERIMENTAL
Intervention: Paracetamol
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 67

Group type: COMPARATOR
Intervention: Tepid sponging alone
Number of subjects: 67

Group type: EXPERIMENTAL
Intervention: Paracetamol with tepid sponging
Number of subjects: 67
Study: 30138237

Group type: EXPERIMENTAL
Intervention: CMJ AS (Countermovement Jump with Arm Swing)
Number of subjects: 22

Group type: COMPARATOR
Intervention: CMJ NAS (Countermovement Jump without Arm Swing)
Number of subjects: 22
Study: 31557258

Group type: EXPERIMENTAL
Intervention: Walking on sand
Number of subjects: 59

Group type: COMPARATOR
Intervention: Walking on stable ground
Number of subjects: 59
Study: 28004319

Group type: EXPERIMENTAL
Intervention: Lower depressive symptoms
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Lower HIV-related stigma
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Higher social support
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Higher physical functioning
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: Higher general health perceptions
Number of subjects: 178
Study: 26275751

Group type: EXPERIMENTAL
Intervention: EAT-AIG thickness measured using echocardiography
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: EAT-RV thickness measured using echocardiography
Number of subjects: 311

Group type: EXPERIMENTAL
Intervention: EAT-AIG thickness for predicting CAD
Number of subjects: 311
Study: 23371755

Group type: EXPERIMENTAL
Intervention: Etoricoxib 60 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 21762493

Group type: EXPERIMENTAL
Intervention: Zhizhu pills containing immature orange fruit of Citrus aurantium L. (IFCA), 6 g each time, 3 times a day for 4 weeks
Number of subjects: 160

Group type: COMPARATOR
Intervention: Zhizhu pills containing immature orange fruit of Citrus sinensis Osbeck (IFCS), 6 g each time, 3 times a day for 4 weeks
Number of subjects: 160
Study: 19339139

Group type: EXPERIMENTAL
Intervention: Context-tailored training (CTT) model
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard 2-day MI workshop
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counselors with more formal education
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Counselors with less endorsement of a disease model of addiction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Agencies with counselors viewing their organization as more open to change
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Posttraining activities supporting ongoing learning and implementation of MI
Number of subjects: 0
Study: 16728696

Group type: EXPERIMENTAL
Intervention: Alemtuzumab-containing conditioning regimen and autologous stem cell transplantation (auto-SCT)
Number of subjects: 7
Study: 15302014

Group type: EXPERIMENTAL
Intervention: Comprehensive hospital discharge planning and close follow-up at a HF clinic
Number of subjects: 338

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 338
Study: 11027879

Group type: EXPERIMENTAL
Intervention: Radiation-induced hyper intensity area (RIHA) in glioma patients
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Normal appearing white matter (NAWM) in glioma patients
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Comparison of NAA and Cr between RIHA and NAWM in glioma patients
Number of subjects: 9
Study: 8646223

Group type: EXPERIMENTAL
Intervention: SLE patients
Number of subjects: 24
Study: 1502484

Group type: EXPERIMENTAL
Intervention: Cisapride 10 mg tablets three times daily for 4 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 6497518

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide therapy (2 weeks)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide therapy (4 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 30767964

Group type: EXPERIMENTAL
Intervention: Group dynamics-based exercise
Number of subjects: 26

Group type: COMPARATOR
Intervention: Personal training
Number of subjects: 26